LABP — Landos Biopharma Share News
0.000.00%
Last trade - 00:00Landos Biopharma Inc reports results for the quarter ended in March - Earnings Summary
U.S. RESEARCH ROUNDUP-Humacyte, Hyatt Hotels, Poseida Therapeutics
Landos Biopharma Inc expected to post a loss of 31 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Lixte Biotechnology, Boeing Co, Worksport Ltd
U.S. STOCKS ON THE MOVE-Astra Space, Biodesix Inc, Kohl's Corp
U.S. STOCKS ON THE MOVE-Meta Platforms, Lixte, Kohl's Corp, BioCardia
U.S. STOCKS ON THE MOVE-Aeglea Bio, CrowdStrike Holdings, Hoth Therapeutics
Jefferies cuts PT for Landos Biopharma over uncertain pipeline prospects
Landos Biopharma falls after Raymond James slashes PT
Brief: Landos Biopharma Files For Mixed Shelf Of Up To $200 Million
Brief: Landos Biopharma Reports Fourth Quarter And Full Year 2021 Results
Landos Biopharma Inc expected to post a loss of 33cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Rivian, Darden Restaurants, General Motors, FedEx
U.S. STOCKS ON THE MOVE-Rivian, FedEx, General Motors, Cerner
Landos Biopharma Inc reports results for the quarter ended in September - Earnings Summary
Brief: Landos Biopharma Reports Q3 Loss Per Share $0.32
Landos Biopharma Inc expected to post a loss of 44 cents a share - Earnings Preview
Brief: Landos Biopharma Announces Leadership Transition
Brief: Landos Biopharma Announces First Subject Dosed In A Phase 1 Study Of Labp-104 For Systemic Lupus Erythematosus